The safety data of cohort 2 of allergic rhinitis immunotherapy trial passed SRT(Safety review team) reviewing and got permission to enter cohort 3.
The safety data of cohort 2 of allergic rhinitis immunotherapy trial passed SRT(Safety review team) reviewing and got permission to enter cohort 3.
2020-03-26